Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly's RET-Inhibitor in Non-Small Cell Lung Cancer in Japan
Oncomine Dx Target Test Receives MHLW Approval as a Companion Diagnostic for Eli Lilly’s RET-Inhibitor in Non-Small Cell Lung Cancer in Japan CARLSBAD, Calif., Sept. 10, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the Japan Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency, has granted approval for the Oncomine Dx Target Test as... Read more